腎交感神經阻斷術的全球市場（2023-2030）：按類型（導管、射頻產生器）和技術（高頻、超音波）分類的規模、佔有率、成長分析和預測

全球腎交感神經阻斷術市場規模將從2021年的2,1949萬美元成長到2022年的3,0882萬美元，預測期內年複合成長率為40.7%，到2030年將成長到107477萬美元。

全球腎交感神經阻斷術市場近年來經歷了顯著成長，預計未來將保持上升趨勢。腎交感神經阻斷術市場的成長是由全球高血壓盛行率的增加以及人們對去腎交感神經阻斷術的益處的認知不斷提高所推動的。與高血壓相關的健康問題日益嚴重，增加了對有效替代療法（如腎交感神經阻斷術）的需求。其他好處包括減少對藥物治療的依賴和改善患者的治療結果，從而導致醫療保健專業人員和患者擴大採用該藥物。此外，醫療設備的技術進步也在推動市場成長方面發揮著重要作用。腎交感神經阻斷術手術現在結合了具有射頻或超音波能量的創新導管系統，以選擇性地消融腎神經。這些技術改進提高了程序的準確性和安全性，進一步促進了其採用。

然而，另一方面，腎交感神經阻斷術市場仍存在一些問題。一個主要障礙是缺乏長期臨床資料來證實手術的持續有效性和安全性。儘管早期研究已顯示出有希望的結果，但仍需要更多證據來確定腎交感神經阻斷術作為高血壓的標準治療方法。

本報告調查了全球腎交感神經阻斷術市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及按不同細分市場和地區進行的細分。總結了主要企業的細分、競爭形勢和概況。

目錄

• 執行摘要
• 調查方法
• 母市場分析
  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
• 關鍵市場洞察
  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 重點投資分析
  • 關鍵成功因素
  • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
  • 法規狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
• 全球腎交感神經阻斷術市場：按類型
  • 市場概況
  • 導管
  • 射頻發生器
  • 神經調節劑
• 全球腎交感神經阻斷術市場：依技術分類
  • 市場概況
  • 高頻
  • 超音波
  • 微量輸液
• 全球腎交感神經阻斷術市場：按地區
  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
• 競爭形勢
  • 前5名企業對比
  • 主要企業市場地位
  • 主要企業的招募策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率
• 主要企業簡介
  • Medtronic
  • Boston Scientific Corporation
  • ReCor Medical
  • Ablative Solutions
  • Mercator MedSystems
  • Terumo Corporation
  • St. Jude Medical (Abbott Laboratories)
  • CardioSonic
  • Symple Surgical
  • Soundbite Medical Solutions
  • Vessix Vascular (Boston Scientific)
  • Renal Dynamics (Boston Scientific)
  • Kona Medical
  • Ablacon
  • Cardiosonic Ltd.
  • EndoCross Ltd.
  • Caldus Medical
  • OxSonics
  • Nexeon MedSystems
  • Johnson & Johnson

Global Renal Denervation Market size was valued at USD 219.49 million in 2021 and is poised to grow from USD 308.82 million in 2022 to USD 1,074.77 million by 2030, at a CAGR of 40.7% during the forecast period (2023-2030).

The global market for renal denervation has experienced significant growth in recent years and is poised to maintain its upward trajectory. Renal denervation is a minimally invasive medical procedure employed to manage hypertension, targeting the renal nerves responsible for regulating blood pressure. The market's expansion is driven by the increasing prevalence of hypertension on a global scale and a growing awareness of the advantages associated with renal denervation. A key driving force behind the renal denervation market is the rising incidence of hypertension, a major contributor to cardiovascular diseases. Given the ongoing global health concern surrounding hypertension, there is a mounting demand for effective treatment alternatives like renal denervation. Additionally, the procedure offers numerous benefits, including reduced reliance on medication and enhanced patient outcomes, thereby prompting its adoption by healthcare providers and patients alike. Moreover, technological advancements in medical devices have played a significant role in driving market growth. Renal denervation procedures now incorporate innovative catheter systems equipped with either radiofrequency or ultrasound energy for the selective ablation of renal nerves. These technological enhancements have heightened the precision and safety of the procedure, further stimulating its adoption. However, challenges confront the renal denervation market. A prominent obstacle is the absence of long-term clinical data confirming the sustained efficacy and safety of the procedure. While initial studies have shown promising results, additional evidence is required to establish renal denervation as a standard treatment option for hypertension.

Top-down and bottom-up approaches were used to estimate and validate the size of the global renal denervation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global Renal Denervation Market is segmented on the basis of type, technology, and region. By type, the market is segmented into catheters, RF generators, and nerve modifying agents. By technology, the market is segmented into radiofrequency, ultrasound, and micro-infusion. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Technological Advancements

The growth of the market is being propelled by developments in renal denervation technologies, which encompass refined catheter designs, more efficient energy delivery systems, and novel agents for modifying nerves. These innovations significantly improve the procedure's accuracy, safety, and overall effectiveness.

Growing Awareness and Acceptance

The growth of the market is being propelled by a rising awareness of the advantages of renal denervation among both patients and healthcare professionals. This procedure provides benefits that include a decreased need for medication, enhanced management of blood pressure, and the potential for long-term positive outcomes.

Restraints:

Limited Awareness and Adoption in Emerging Markets

Limited awareness and comprehension of renal denervation as a hypertension treatment option may exist in certain developing markets. This deficiency in knowledge, when combined with inadequate healthcare infrastructure, can act as hindrances to market expansion in these areas.

Procedural Complexity and Learning Curve

Renal denervation is a procedure characterized by its technical intricacy, demanding specialized training and proficiency. The intricacies of the procedure and the time it takes to become proficient in it may restrict its widespread utilization, particularly among healthcare providers who are less experienced in this field.

Market Trends:

Transition to Outpatient Renal Denervation: There is an emerging tendency to conduct renal denervation procedures in outpatient or ambulatory settings as opposed to traditional hospital environments. This transition is motivated by factors such as cost-efficiency, patient convenience, and a reduction in the need for hospitalization. Shifting renal denervation to ambulatory settings can expand patient accessibility and promote market growth.

Patient-Focused Strategy: Healthcare providers and entities within the renal denervation sector are increasingly embracing a patient-centric strategy. The emphasis is on delivering customized care, enhancing patient outcomes, and elevating the patient experience throughout the entire renal denervation process. This trend corresponds with the broader movement towards value-based healthcare.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Renal Denervation Market by Type
  • Market Overview
  • Catheters
  • RF generators
  • and nerve modifying agents
• Global Renal Denervation Market by Technology
  • Market Overview
  • Radiofrequency
  • ultrasound
  • and micro-infusion
• Global Renal Denervation Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Medtronic - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boston Scientific Corporation - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ReCor Medical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ablative Solutions - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mercator MedSystems - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Terumo Corporation - Japan
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • St. Jude Medical (Abbott Laboratories) - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • CardioSonic - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Symple Surgical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Soundbite Medical Solutions - Canada
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Vessix Vascular (acquired by Boston Scientific) - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Renal Dynamics (acquired by Boston Scientific) - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Kona Medical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ablacon - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cardiosonic Ltd. - Israel
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • EndoCross Ltd. - Israel
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Caldus Medical - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • OxSonics - United Kingdom
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Nexeon MedSystems - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Johnson & Johnson - United States
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments